Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer and Its Relation With Disease Stages, Pathological Types and Grading

NCT05542940 is registered in ClinicalTrials.gov with Hossam Hassan Aly Hassan El Sokkary as lead sponsor.

NCT NCT05542940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05542940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer and Its Relation With Disease Stages, Pathological Types and Grading
Lead sponsor
Hossam Hassan Aly Hassan El Sokkary
Phase
Observational
Overall status
Completed
Start date
January 1, 2020
Completion date
August 31, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer